Biotech China 2014
The 2nd International Conference on Prehypertension and CardioMetabolic Syndrome
Hotel Rey Juan Carlos
Avinguda Diagonal, 661 08028
Barcelona, Spain
Prehypertension, Nervous System, Cardio Metabolic Risk

Schedule of Presentations:

Thursday, January 31, 2013
14:00:00 Registration
18:00:00 Opening Ceremony followed by Get-Together Reception
Friday, February 1, 2013
08:00:00 Registration
08:30:00 Plenary Opening Session: Pathogenesis of PreHypertension Reuven Zimlichman, Luis M. Ruilope
08:30:00 PreHypertension – Extension of Normalcy or Genetically Different Population Stevo Julius
09:00:00 Blood Pressure Reactivity and Variability in PreHypertension Giuseppe Mancia
09:30:00 Sympathetic Activity and the Kidney Hermann Haller
10:00:00 Sympathetic Hyperactivity and the Metabolic Syndrome in Hypertension Stevo Julius
10:30:00 Coffee Break, Exhibition Visit and E-Posters Viewing
11:00:00 Plenary Opening Session: Mechanisms of Pre Disease Anthony M. Heagerty, Thomas Unger
11:00:00 Early Endothelial Dysfunction - How the Vasculature Recognizes Risk Factors and Turns them into Disease Hermann Haller
11:30:00 Is it Time to Change the Definitions of Hypertension and to Change the Risk Tables? Reuven Zimlichman
12:00:00 Perivascular Fat in Hypertension and Diabetes Anthony M. Heagerty
12:30:00 Discussion Panel
13:00:00 Lunch Break, Exhibition Visit and E-Posters Viewing
14:00:00 Plenary Session: Subclinical End Organ Damage in PreHypertension Giuseppe Mancia
14:00:00 Vascular Abnormalities Daniel A. Duprez
14:20:00 CV Risk in PreHypertension Luis M. Ruilope
14:40:00 Correlates of Volume Control in Early Hypertension Peter de Leeuw
15:00:00 Albuminuria as an Early Indicator of Organ Damage Bruno Watschinger
15:20:00 Why Subjects with PreHypertension Should be Screened for Subclinical Organ Damage
16:10:00 Plenary Session: Hemodynamics, Arteries and Humoral Factors Daniel A. Duprez
16:10:00 Role of Arterial Stiffening in the Genesis of Hypertension Ian B. Wilkinson
16:30:00 Hemodynamic Changes in PreHypertension Stevo Julius
16:50:00 Job Strain - Can it be Prevented?
17:10:00 New Guidelines of the ESC, What We Can Expect of Them
17:30:00 Controversy Discussion: Blood Pressure Reactivity in Hypertension Giuseppe Schillaci
17:30:00 Increased Sverre E. Kjeldsen
17:50:00 Decreased Stevo Julius
18:10:00 Discussion
Saturday, February 2, 2013
00:00:00 The PREVER Study Flavio D. Fuchs
00:20:00 Studies on Regression from Hypertension to PreHypertension Hiroyuki Sasamura
00:40:00 Panel Discussion: What We Have Learnt from Population Studies and Which Studies Do We Need? Stevo Julius
01:00:00 Lunch Break, Exhibition Visit and E-Posters Viewing
08:20:00 Registration
08:30:00 Satellite Symposium: Blood Pressure PWA - Novel Methodology for Early Detection and Intervention John R. Cockcroft, Luis M. Ruilope
08:30:00 Part I: Current Opportunities for Blood Pressure PWA in Clinical Research John R. Cockcroft
09:00:00 Part II: Early Detection Markers of Cardio Vascular Risk
10:00:00 Part III - Validation and Clinical Application Thomas Weber
10:30:00 Coffee Break, Exhibition Visit and E-Posters Viewing
11:00:00 Plenary Session: Lessons from Population Studies Basil S. Lewis, Sverre E. Kjeldsen
11:00:00 Population Studies in PreHypertension, Review Sverre E. Kjeldsen
11:20:00 Baseline Data of the CHINOM Study
11:40:00 The Harvest Study Paolo Palatini
14:00:00 Can an Endothelial Model Explain the Beneficial Effect of Different Carotenoids in PreHypertension Esther Paran
14:00:00 Cardiovascular Risk Factors and Cognitive Decline in Older Adults: A Population Based Cohort Study Alex Dregan
14:30:00 An I1-Imidazoline Receptor Agonist Causes Sympatho-Inhibition and Adiponectin Secretion Stimulation in Rats: A New Way To Treat Metabolic Syndrome? Nathalie Niederhoffer
14:45:00 Sodium Sensitivity, Renal and Extra-Renal Mechanisms of Fluid Control and the Micro-Circulation: Relevance to Hypertension based on Studies in Normotensive Subjects
15:00:00 Development of Ischaemic Heart Disease in People with Metabolic Syndrome (ESCARVAL Study) Domingo Orozco-Beltrán
15:15:00 Sympathetic Overactivity as an Early Manifestation of Metabolic Syndrome Pascal Bousquet
15:30:00 Coffee Break, Exhibition Visit and E-Posters Viewing
16:00:00 The Good Side of the RAS; Beneficial Effects of Direct AT2 Receptor Stimulation Thomas Unger
16:00:00 Plenary Session: PreHypertension, Diabetes and the Metabolic Syndrome Mechanisms Siddharth Jadhav
16:20:00 Mitochondrial Dysfunction in the Diabetic Endothelium
16:40:00 Statins and the Risk of Diabetes: Should We Be Afraid of That Maciej Banach
17:00:00 New Perspectives in the Management of Metabolic Syndrome
17:20:00 Pre-Diabetes, Metabolic Syndrome and Cardiovascular Risk
17:40:00 The High Risk Plaque Initiative Oliver Steinbach
20:00:00 Gala Dinner
Sunday, February 3, 2013
08:00:00 Registration
08:30:00 Plenary Session: PreHypertension - Risks and Mechanisms Charalambos Vlachopoulos
08:30:00 PreHypertension; A Risk Factor for Cardiovascular Events Raimund Erbel
08:50:00 PreHypertension and the Risk of Stroke Cetin Erol
09:10:00 Secondary Prevention Therapies in IHD: The Yentl Syndrome Raffaele Bugiardini
09:30:00 Companion Diagnostics as a Tool in Prevention of Complications of Hypertension Pavel Hamet
09:50:00 Impact of Metabolic Syndrome on Acute Coronary Events Giuseppe Ambrosio
10:10:00 Association between Pre-Hypertension, Chronic Kidney Disease and Vitamin D Alexander Rosenkranz
10:30:00 Coffee Break, Exhibition Visit and E-Posters Viewing
11:00:00 Plenary Session: Understanding and Evaluation of PreHypertension –Vascular Aspects Giuseppe Schillaci
11:00:00 Arterial Stiffness and Central Hemodynamics across the Adult Lifespan - Mechanisms Driving Hypertension
11:20:00 Arterial Stiffness and Central Blood Pressure - Any Improvement in Cardiovascular Risk Assessment? Giuseppe Schillaci
12:00:00 Debate: The Use of Beta Blockers in Hypertension/PreHypertension Ian B. Wilkinson, Giuseppe Schillaci
12:30:00 Final Conclusions: Evaluation, Diagnosis, Treatment and the Need for Guidelines Giuseppe Mancia, Luis M. Ruilope, Hermann Haller, Reuven Zimlichman, Daniel A. Duprez, Basil S. Lewis
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.